Clinical Trial - Trial ChiCTR2100049349
Access comprehensive clinical trial information for ChiCTR2100049349 through Pure Global AI's free database. This Phase 1 trial is sponsored by Shulan (Hangzhou) Hospital and is currently Not yet recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2100049349
Phase 1
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2100049349
View on Chinese Clinical Trial Registry
Untitled Trial
Phase I clinical trial to evaluate the safety, tolerability and preliminary explored immunogenicity of the new coronavirus mRNA vaccine (LVRNA009) in Chinese people aged 18 years and over
Study Focus
Sponsor & Location
Shulan (Hangzhou) Hospital
Self financed
China
Timeline & Enrollment
Phase 1
N/A
Dec 31, 2022
ICD-10 Classifications
COVID-19, virus identified
Viral pneumonia, unspecified
Other viral pneumonia
COVID-19, virus not identified
Pneumonia in viral diseases classified elsewhere
Data Source
Chinese Clinical Trial Registry
ChiCTR2100049349
Non-Device Trial